A Potential Role of Indoleamine 2,3-Dioxygenase–Specific T cells in Leishmania Vaccination

Por Straten, Per thor, Andersen, Mads Hald
Publicado em 2011

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment

Por Pedersen, Sara R, Straten, Per Thor
Publicado no J Immunother Cancer (2015)

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

Por Donia, Marco, Ellebaek, Eva, Andersen, Mads Hald, Straten, Per thor, Svane, Inge Marie
Publicado em 2012

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

Por Larsen, Stine Kiaer, Hansen, Morten, Svane, Inge Marie, Straten, Per Thor, Andersen, Mads Hald
Publicado em 2012

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses

Por Køllgaard, Tania, Klausen, Tobias Wirenfeldt, Idorn, Manja, Holmgaard, Rikke Bæk, Straten, Per thor, Andersen, Mads Hald
Publicado em 2012

Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes

Por Køllgaard, Tania, Ugurel-Becker, Selma, Idorn, Manja, Andersen, Mads Hald, Becker, Jürgen C., Straten, Per thor
Publicado no PLoS One (2015)

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

Por Donia, Marco, Fagone, Paolo, Nicoletti, Ferdinando, Andersen, Rikke Sick, Høgdall, Estrid, Straten, Per thor, Andersen, Mads Hald, Svane, Inge Marie
Publicado em 2012

Cancer immunotherapy: from the lab to clinical applications—Potential impact on cancer centres’ organisation

Por Cairns, Linda, Aspeslagh, Sandrine, Anichini, Andrea, Kyte, Jon Amund, Blank, Christian, Ascierto, Paolo, Rekers, Nicolle, Straten, Per Thor, Awada, Ahmad
Publicado no Ecancermedicalscience (2016)

Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

Por Jørgensen, Nicolai Grønne, Ahmad, Shamaila Munir, Abildgaard, Niels, Straten, Per Thor, Svane, Inge Marie, Andersen, Mads Hald, Knudsen, Lene Meldgaard
Publicado no Stem Cell Investig (2016)

Spontaneous presence of FOXO3-specific T cells in cancer patients

Por Larsen, Stine Kiaer, Ahmad, Shamaila Munir, Idorn, Manja, Met, Özcan, Martinenaite, Evelina, Svane, Inge Marie, Straten, Per thor, Andersen, Mads Hald
Publicado no Oncoimmunology (2014)

Natural CD4(+) T-Cell Responses against Indoleamine 2,3-Dioxygenase

Por Munir, Shamaila, Larsen, Stine Kiaer, Iversen, Trine Zeeberg, Donia, Marco, Klausen, Tobias Wirenfeldt, Svane, Inge Marie, Straten, Per thor, Andersen, Mads Hald
Publicado em 2012

Role of signal transduction and microRNAs on the immunogenicity of melanoma cells

Por Meyer, Stefanie, Handke, Diana, Mueller, Anja, Meinhardt, Anne, Jasinski-Bergner, Simon, Mages, Stephan, Bukur, Juergen, Donia, Marco, Straten, PerThor, Seliger, Barbara
Publicado no J Transl Med (2015)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma

Por Andersen, Rikke, Donia, Marco, Borch, Troels Holz, Steensgaard, Eva Ellebæk, Iversen, Trine Zeeberg, Kongsted, Per, Andersen, Mads Hald, Straten , Per thor, Svane, Inge Marie
Publicado no J Immunother Cancer (2014)

T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from healthy donors

Por Lyngaa, Rikke, Pedersen, Natasja Wulff, Schrama, David, Thrue, Charlotte Albæk, Ibrani, Dafina, Met, Özcan, Straten, Per thor, Nghiem, Paul, Becker, Jürgen C., Hadrup, Sine Reker
Publicado em 2014

Inflammation induced PD-L1-specific T cells

Por Munir, Shamaila, Lundsager, Mia Thorup, Jørgensen, Mia Aabroe, Hansen, Morten, Petersen, Trine Hilkjær, Bonefeld, Charlotte Menne, Friese, Christina, Met, Özcan, Straten, Per thor, Andersen, Mads Hald
Publicado no Cell Stress (2019)

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients

Por Viborg, Nadia, Ramskov, Sofie, Andersen, Rikke Sick, Sturm, Theo, Fugmann, Tim, Bentzen, Amalie Kai, Rafa, Vibeke Mindahl, Straten, Per thor, Svane, Inge Marie, Met, Özcan, Hadrup, Sine Reker
Publicado no Oncoimmunology (2019)

The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase

Por Sørensen, Rikke Bæk, Berge-Hansen, Linda, Junker, Niels, Hansen, Christina Aaen, Hadrup, Sine Reker, Schumacher, Ton N. M., Svane, Inge Marie, Becker, Jürgen C., Straten, Per thor, Andersen, Mads Hald
Publicado em 2009

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

Por Hjortsø, Mads Duus, Larsen, Stine Kiaer, Kongsted, Per, Met, Özcan, Frøsig, Thomas Mørch, Andersen, Gitte Holmen, Ahmad, Shamaila Munir, Svane, Inge Marie, Becker, Jürgen C, Straten, Per thor, Andersen, Mads Hald
Publicado no Oncoimmunology (2015)

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygena...

Por Iversen, Trine Z, Engell-Noerregaard, Lotte, Ellebaek, Eva, Andersen, Rikke, Larsen, Stine K, Bjoern, Jon, Zeyher, Claus, Gouttefangeas, Cécile, Thomsen, Birte M, Holm, Bente, Straten, Per thor, Mellemgaard, Anders, Andersen, Mads H, Svane, Inge M
Publicado em 2013

Collagen density regulates the activity of tumor-infiltrating T cells

Por Kuczek, Dorota E., Larsen, Anne Mette H., Thorseth, Marie-Louise, Carretta, Marco, Kalvisa, Adrija, Siersbæk, Majken S., Simões, Ana Micaela C., Roslind, Anne, Engelholm, Lars H., Noessner, Elfriede, Donia, Marco, Svane, Inge Marie, Straten, Per thor, Grøntved, Lars, Madsen, Daniel H.
Publicado no J Immunother Cancer (2019)